New Guidelines Enhance Diagnosis and Treatment of Inflammatory Bowel Disease
Updated guidelines developed by the University of Nottingham aim to help clinicians diagnose and treat inflammatory bowel disease more accurately and rapidly, emphasizing early, effective therapy for better patient outcomes.
Scientists and clinicians at the University of Nottingham have developed updated guidelines to improve the management of inflammatory bowel disease (IBD), including Crohn's disease and ulcerative colitis. These new recommendations aim to enable healthcare providers to diagnose and treat IBD more accurately, efficiently, and effectively.
The revised guidelines, published in the journal BMJ Gut, serve as an evidence-based roadmap for the diagnosis, medical, and surgical management of IBD. They address critical areas such as the management of special conditions like pregnancy, treatment of extraintestinal manifestations, and drug monitoring. Importantly, these guidelines introduce a top-down therapy approach for the first time, advocating for early use of the most effective drugs rather than escalating treatment based on patient response.
Commissioned by the British Society of Gastroenterology (BSG), the guidelines build upon the previous 2019 version and incorporate the latest research, including extensive evidence syntheses and network meta-analyses. Developed using the GRADE methodology, they offer clear, practical recommendations intended to assist clinicians both nationally and internationally.
Professor Gordon Moran of the University of Nottingham emphasized the importance of these guidelines, highlighting the comprehensive review of therapeutic agents for remission induction and maintenance in IBD. The collaboration involved experts, generalists, and patients, ensuring the guidance reflects current evidence and real-world needs.
These updates are part of a wider effort to streamline diagnostic pathways and promote high-quality, multidisciplinary care for IBD patients. The guidelines are expected to facilitate quicker, more precise diagnosis and optimal treatment strategies, ultimately improving patient outcomes and quality of life.
Source: https://medicalxpress.com/news/2025-06-guidance-inflammatory-bowel-disease-quicker.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Enhanced Access to Social Support Programs Boosts Treatment for Women with Drug Use Disorders
A new study reveals that combining Medicaid with social support services significantly increases treatment access for women with drug and opioid use disorders. Expanded social safety net programs can help address treatment gaps and barriers faced by women with substance use issues.
Gender Differences in Brain Response to Alcohol: Females Show Greater Biochemical Sensitivity Long Before Dependence Develops
New research reveals that females may experience more biochemical sensitivity to alcohol early on, influencing treatment strategies for alcohol use disorder. Discover how sex differences affect brain response and potential targeted therapies.
Research Highlights Ethnic and Socioeconomic Disparities in Stillbirths Across Hospitals in England
A groundbreaking study reveals persistent ethnic and socioeconomic disparities in stillbirth rates within hospitals across England, highlighting the urgent need for equitable maternity care.
Maple Leafs' Goalkeeper Anthony Stolarz's Injury Sparks Concerns Over Concussions in Ice Hockey
The injury of Maple Leafs' goalie Anthony Stolarz during the playoffs highlights ongoing concerns about concussion risks and brain injuries in ice hockey, emphasizing the need for improved prevention and management strategies.